Benign prostatic hyperplasia: a new metabolic disease?

Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism

(2014) A. Lenzi et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Androgen regulation of prostate cancer: Where are we now?

(2014) G. Corona et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Interleukin 8 and the male genital tract

(2013) Francesco Lotti et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Serum PSA as a Predictor of Testosterone Deficiency

(2013) Giulia Rastrelli et al.   Journal of Sexual Medicine

Testosterone Supplementation does not Worsen Lower Urinary Tract Symptoms

(2013) Jeffrey A. Pearl et al.   JOURNAL OF UROLOGY

Risk Factors for Progression or Improvement of Lower Urinary Tract Symptoms in a Prospective Cohort of Men

(2013) Sean Martin et al.   JOURNAL OF UROLOGY

Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits

(2013) Annamaria Morelli et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS

(2013) Linda Vignozzi et al.   PROSTATE

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER?

(2013) P. Comeglio et al.   PROSTATE

Testosterone Replacement Alone for Testosterone Deficiency Syndrome Improves Moderate Lower Urinary Tract Symptoms: One Year Follow-Up

(2013) Young Hwii Ko et al.   World Journal of Mens Health

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

(2012) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

(2012) Annamaria Morelli et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

(2012) Linda Vignozzi et al.   PROSTATE

Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit

(2012) Annamaria Morelli et al.   PROSTATE

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation

(2012) M Gacci et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Associations Between Longitudinal Changes in Serum Estrogen, Testosterone, and Bioavailable Testosterone and Changes in Benign Urologic Outcomes

(2011) J. L. St. Sauver et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Risk stratification for benign prostatic hyperplasia (BPH) treatment

(2011) Mark Emberton et al.   BJU INTERNATIONAL

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

(2011) Tristan M. Nicholson et al.   DIFFERENTIATION

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

(2011) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Body mass index and risk of BPH: a meta-analysis

(2011) S Wang et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study

(2010) Kazuyoshi Shigehara et al.   Aging Male

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia

(2010) Luciano Adorini et al.   Annals of the New York Academy of Sciences

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

(2010) Hermann M. Behre et al.   CLINICAL ENDOCRINOLOGY

Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function

(2010) Aravinda K. Chavalmane et al.   Journal of Sexual Medicine

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men

(2009) A. Haider et al.   ANDROLOGIA

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia

(2009) B. Fibbi et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation

(2009) G. Penna et al.   JOURNAL OF IMMUNOLOGY

Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome

(2009) Sandra Filippi et al.   Journal of Sexual Medicine

Age-Related Changes in General and Sexual Health in Middle-Aged and Older Men: Results from the European Male Ageing Study (EMAS)

(2009) Giovanni Corona et al.   Journal of Sexual Medicine

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH

(2009) Stavros Gravas et al.   WORLD JOURNAL OF UROLOGY

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study

(2008) S. Kalinchenko et al.   Aging Male

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

(2008) Sinan KarazindiyanoĞlu et al.   Aging Male

Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth

(2008) Abraham Morgentaler et al.   EUROPEAN UROLOGY

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

(2008) J Hammarsten et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Association Between Lower Urinary Tract Symptoms and Serum Levels of Sex Hormones in Men

(2008) Yoshiji Miwa et al.   UROLOGY

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

(2007) J. Curtis Nickel et al.   EUROPEAN UROLOGY

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms

(2007) Karen S. Sfanos et al.   PROSTATE